NON-SMALL-CELL LUNG
Clinical trials for NON-SMALL-CELL LUNG explained in plain language.
Never miss a new study
Get alerted when new NON-SMALL-CELL LUNG trials appear
Sign up with your email to follow new studies for NON-SMALL-CELL LUNG, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope: boosting chemo before lung cancer surgery shows promise
Disease control CompletedThis study tested whether adding an immunotherapy drug (atezolizumab) to standard chemotherapy before surgery helps people with operable non-small cell lung cancer. It involved 453 participants who were randomly assigned to receive either the real drug or a placebo alongside chem…
Matched conditions: NON-SMALL-CELL LUNG
Phase: PHASE3 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Apr 03, 2026 14:42 UTC
-
Major trial tests new drug combo in fight against advanced lung cancer
Disease control CompletedThis large, completed study tested whether adding the drug aflibercept to standard chemotherapy (docetaxel) helped people with advanced non-small cell lung cancer live longer. It involved over 900 participants whose cancer had worsened after one prior platinum-based treatment. Th…
Matched conditions: NON-SMALL-CELL LUNG
Phase: PHASE3 • Sponsor: Sanofi • Aim: Disease control
Last updated Mar 05, 2026 14:00 UTC